FTC sues Hims & Hers for allegedly sharing patients’ medical data with advertisers Meta and Snap
The U.S. federal consumer watchdog said Hims & Hers, which prescribes for sexual wellness and mental health conditions, used website trackers to share customers' information with advertisers.
The Federal Trade Commission's lawsuit against Hims & Hers raises significant concerns about the handling of sensitive patient data in the digital health space. The allegations that the company shared customers' medical information with advertisers Meta and Snap without consent highlights the risks of using tracking technologies on healthcare websites. This is particularly troubling given the intimate nature of the health conditions Hims & Hers treats.
The use of website trackers, such as pixels and cookies, is common in the online industry, but healthcare providers have a heightened responsibility to protect patient confidentiality. The FTC's action suggests that regulators are scrutinizing the data practices of digital health companies, and Hims & Hers may face substantial penalties if found liable. This case has implications for the broader healthcare and technology industries, where data sharing and monetization are increasingly common.
As the digital health landscape continues to evolve, it's essential to watch how this lawsuit unfolds and its potential impact on data sharing practices in the industry. Companies handling sensitive patient information must prioritize transparency and security to maintain trust. The FTC's action may signal a new era of stricter enforcement, and tech companies would do well to review their data handling practices to ensure compliance with regulations like HIPAA and the FTC Act.
Originally reported by techcrunch.com. NewsChannels adds analysis for technology readers.